These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10419460)
21. Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator. Komissarov AA; Declerck PJ; Shore JD J Biol Chem; 2004 May; 279(22):23007-13. PubMed ID: 15033993 [TBL] [Abstract][Full Text] [Related]
22. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells. Ekhterae D; Stanley JC J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475 [TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator. Hekman CM; Loskutoff DJ Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176 [TBL] [Abstract][Full Text] [Related]
24. Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitro. Stringer KA; Lindenfeld J; Repine AJ; Cohen Z; Repine JE Inflammation; 1997 Feb; 21(1):27-34. PubMed ID: 9179619 [TBL] [Abstract][Full Text] [Related]
31. Maspin inhibits cell migration in the absence of protease inhibitory activity. Bass R; Fernández AM; Ellis V J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513 [TBL] [Abstract][Full Text] [Related]
32. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface. Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318 [TBL] [Abstract][Full Text] [Related]
33. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Bangalore N; Drohan WN; Orthner CL Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799 [TBL] [Abstract][Full Text] [Related]
34. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage. Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions. Chmielewska J; Rånby M; Wiman B Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797 [TBL] [Abstract][Full Text] [Related]
37. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
38. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites. Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898 [TBL] [Abstract][Full Text] [Related]
39. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells. Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044 [TBL] [Abstract][Full Text] [Related]
40. Binding of tissue plasminogen activator to human umbilical vein endothelial cells. Beebe DP Thromb Res; 1987 Apr; 46(2):241-54. PubMed ID: 3111002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]